3,4,3',4'-tetrachloroazobenzene has been researched along with Urethral Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhusari, S; Hoenerhoff, MJ; Hong, HH; Hooth, MJ; Lea, IA; Malarkey, DE; Masinde, T; Nolan, M; Sills, RC; Vasconcelos, D; Wang, Y | 1 |
| Hooth, MJ; Johansson, SL; Kissling, GE; Lieuallen, W; Malarkey, DE; Nyska, A; Singh, BP | 1 |
2 other study(ies) available for 3,4,3',4'-tetrachloroazobenzene and Urethral Neoplasms
| Article | Year |
|---|---|
Mutation spectra of Kras and Tp53 in urethral and lung neoplasms in B6C3F1 mice treated with 3,3',4,4'-tetrachloroazobenzene.
Topics: Animals; Azo Compounds; Chlorobenzenes; DNA Mutational Analysis; Female; Lung Neoplasms; Male; Mice; Mutagens; Mutation; Proto-Oncogene Proteins p21(ras); Tumor Suppressor Protein p53; Urethral Neoplasms | 2014 |
Urethral carcinoma and hyperplasia in male and female B6C3F1 mice treated with 3,3',4,4'-tetrachloroazobenzene (TCAB).
Topics: Animals; Azo Compounds; Carcinogens; Carcinoma, Transitional Cell; Chlorobenzenes; Female; Herbicides; Hyperplasia; Kidney Diseases; Male; Mice; Ureteral Neoplasms; Urethral Diseases; Urethral Neoplasms; Urinary Bladder Neoplasms | 2010 |